Compare EXR & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXR | LH |
|---|---|---|
| Founded | 1977 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 25.9B |
| IPO Year | 2004 | 2005 |
| Metric | EXR | LH |
|---|---|---|
| Price | $132.23 | $308.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $144.80 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.2M | 738.9K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.61% | 1.12% |
| EPS Growth | 13.90 | ★ 18.33 |
| EPS | 2.39 | ★ 6.99 |
| Revenue | $3,377,542,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | N/A | $8.26 |
| Revenue Next Year | $3.63 | $4.81 |
| P/E Ratio | $55.10 | ★ $44.29 |
| Revenue Growth | 3.70 | ★ 7.25 |
| 52 Week Low | $125.71 | $244.52 |
| 52 Week High | $158.88 | $341.80 |
| Indicator | EXR | LH |
|---|---|---|
| Relative Strength Index (RSI) | 33.05 | 40.69 |
| Support Level | $128.34 | $305.45 |
| Resistance Level | $151.04 | $341.80 |
| Average True Range (ATR) | 2.46 | 8.20 |
| MACD | -0.30 | -1.93 |
| Stochastic Oscillator | 16.13 | 20.12 |
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages more than 4,200 self-storage properties in 43 states, with over 330 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.